Reis de Assis Dênis, Maria Rita de Cássia, Borba Rosa Rafael, Schuck Patrícia Fernanda, Ribeiro César Augusto João, da Costa Ferreira Gustavo, Dutra-Filho Carlos Severo, Terezinha de Souza Wyse Angela, Duval Wannmacher Clóvis Milton, Santos Perry Marcos Luiz, Wajner Moacir
Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90035-003, Brazil.
Brain Res. 2004 Dec 24;1030(1):141-51. doi: 10.1016/j.brainres.2004.10.010.
Patients affected by medium-chain acyl CoA dehydrogenase (MCAD) deficiency, a frequent inborn error of metabolism, suffer from acute episodes of encephalopathy. However, the mechanisms underlying the neuropathology of this disease are poorly known. In the present study, we investigated the in vitro effect of the medium-chain fatty acids (MCFA), at concentrations varying from 0.01 to 3 mM, accumulating in MCAD deficiency on some parameters of energy metabolism in cerebral cortex of young rats. (14)CO(2) production from [U(14)] glucose, [1-(14)C] acetate and [1,5-(14)C] citrate was evaluated by incubating cerebral cortex homogenates from 30-day-old rats in the absence (controls) or presence of octanoic acid, decanoic acid or cis-4-decenoic acid. OA and DA significantly reduced (14)CO(2) production from acetate by around 30-40%, and from glucose by around 70%. DA significantly reduced (14)CO(2) production from citrate by around 40%, while OA did not affect this parameter. cDA inhibited (14)CO(2) production from all tested substrates by around 30-40%. The activities of the respiratory chain complexes and of creatine kinase were also tested in the presence of DA and cDA. Both metabolites significantly inhibited cytochrome c oxidase activity (by 30%) and complex II-III activity (DA, 25%; cDA, 80%). Furthermore, only cDA inhibited complex II activity (by 30%), while complex I-III and citrate synthase were not affected by these MCFA. On the other hand, only cDA reduced the activity of creatine kinase in total homogenates, as well as in mitochondrial and cytosolic fractions from cerebral cortex (by 50%). The data suggest that the major metabolites which accumulate in MCAD deficiency, with particular emphasis to cDA, compromise brain energy metabolism. We presume that these findings may contribute to the understanding of the pathophysiology of the neurological dysfunction of MCAD deficient patients.
中链酰基辅酶A脱氢酶(MCAD)缺乏症是一种常见的先天性代谢缺陷病,患者会出现急性脑病发作。然而,这种疾病神经病理学的潜在机制尚不清楚。在本研究中,我们研究了在MCAD缺乏症中积累的浓度为0.01至3 mM的中链脂肪酸(MCFA)对幼鼠大脑皮质能量代谢某些参数的体外影响。通过在不存在(对照)或存在辛酸、癸酸或顺式-4-癸烯酸的情况下孵育30日龄大鼠的大脑皮质匀浆,评估了[U(14)]葡萄糖、[1-(14)C]乙酸盐和[1,5-(14)C]柠檬酸盐产生的(14)CO(2)。辛酸(OA)和癸酸(DA)使乙酸盐产生的(14)CO(2)显著降低约30-40%,使葡萄糖产生的(14)CO(2)显著降低约70%。癸酸使柠檬酸盐产生的(14)CO(2)显著降低约40%,而辛酸不影响该参数。顺式-4-癸烯酸(cDA)使所有测试底物产生的(14)CO(2)降低约30-40%。在存在癸酸和顺式-4-癸烯酸的情况下,还测试了呼吸链复合物和肌酸激酶的活性。两种代谢物均显著抑制细胞色素c氧化酶活性(30%)和复合物II-III活性(癸酸,25%;顺式-4-癸烯酸,80%)。此外,只有顺式-4-癸烯酸抑制复合物II活性(30%),而复合物I-III和柠檬酸合酶不受这些中链脂肪酸的影响。另一方面,只有顺式-4-癸烯酸降低了大脑皮质总匀浆以及线粒体和胞质部分中肌酸激酶的活性(50%)。数据表明,在MCAD缺乏症中积累的主要代谢物,尤其是顺式-4-癸烯酸,损害了大脑能量代谢。我们推测这些发现可能有助于理解MCAD缺乏症患者神经功能障碍的病理生理学。